
Cold-Chain Shipping Notice
This medication requires specialized cold-chain packaging to help maintain its quality and integrity during transit. Each shipment includes a temperature indicator to monitor storage conditions throughout the shipping process.
Do NOT use this medication if the attached temperature indicator shows that it was exposed to temperatures below 2°C (36°F) or above 8°C (46°F). If the temperature indicator shows that the acceptable temperature range has been exceeded, or if you have any concerns about the condition of your shipment upon arrival, do not use the medication and contact our pharmacy immediately for further instructions and assistance.
Please inspect your shipment and the temperature indicator as soon as it is delivered.
What is Stelara?
Stelara (Ustekinumab) is a medication developed by Janssen Biotech. It helps reduce inflammation by targeting specific proteins that cause swelling and immune responses. This medication is a biologic, meaning it modifies the immune system.
Stelara is FDA-approved to treat several conditions:
- Psoriasis: For adults and children aged 6 years and older with moderate to severe psoriasis who might benefit from injections, pills (systemic therapy), or phototherapy (using ultraviolet light).
- Psoriatic Arthritis: For adults and children aged 6 years and older with active psoriatic arthritis.
- Crohn’s Disease: For adults 18 years and older with moderate to severe Crohn’s disease.
- Ulcerative Colitis: For adults 18 years and older with moderate to severe ulcerative colitis.
How does Stelara work?
Stelara works by targeting and blocking two specific proteins, called interleukin-12 (IL-12) and interleukin-23 (IL-23), which are cytokines involved in causing inflammation and triggering immune responses.
These proteins help stimulate the immune system, leading to symptoms like skin plaques, joint pain, and intestinal issues. By attaching to these proteins, Stelara blocks them from working, which reduces the immune system’s overactivity.
This decreases inflammation and the production of skin cells, leading to fewer symptoms and improvement in conditions such as psoriasis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis.
Stelara helps stop the body from attacking itself by blocking the proteins that cause inflammation, resulting in less pain, fewer skin issues, and better overall health.
Dosage Information and Usage
Dosage Form and Strengths
Stelara is a clear to light yellow liquid that might have some small translucent or white particles.
Subcutaneous Injection
- Injection: 45 mg/0.5 mL or 90 mg/mL solution in a single-dose prefilled syringe
- Injection: 45 mg/0.5 mL solution in a single-dose vial
Intravenous Infusion
- Injection: 130 mg/26 mL (5 mg/mL) solution in a single-dose vial
Usage
The dosage and frequency depend on the condition and the patient’s weight. Below are the specific recommendations:
Recommended Dosage in Plaque Psoriasis
Subcutaneous Adult Dosage Schedule:
- For patients weighing 100 kg or less, start with 45 mg initially and repeat after 4 weeks, then every 12 weeks.
- For patients weighing more than 100 kg, start with 90 mg initially and repeat after 4 weeks, then every 12 weeks.
- Studies show both 45 mg and 90 mg are effective, with slightly greater efficacy observed with 90 mg in heavier patients.
Subcutaneous Pediatric Dosage Schedule:
- Administer Stelara subcutaneously at weeks 0 and 4, then every 12 weeks thereafter.
- The dosage depends on body weight, with adjustments for pediatric patients aged 6–17 years old.
Recommended Dosage in Psoriatic Arthritis
Subcutaneous Adult Dosage:
- Start with 45 mg initially and repeat after 4 weeks, then every 12 weeks.
- For patients with co-existent moderate-to-severe plaque psoriasis weighing more than 100 kg, start with 90 mg initially and repeat after 4 weeks, then every 12 weeks.
Subcutaneous Pediatric Dosage:
- Administer Stelara subcutaneously once, again in 4 weeks, then every 12 weeks thereafter.
- The dosage depends on body weight, with adjustments for pediatric patients aged 6–17 years old.
Recommended Dosage in Crohn’s Disease and Ulcerative Colitis
Intravenous Induction Adult Dosage:
- A single intravenous infusion dose is based on patient weight.
- Maintenance dosage is a subcutaneous 90 mg dose administered 8 weeks after the initial intravenous dose, then every 8 weeks thereafter.
General Considerations for Subcutaneous Administration
- Stelara should only be administered under healthcare provider supervision.
- Dosage adjustments should be made based on patient weight and condition.
- Proper subcutaneous injection technique should be followed.
- Stelara solution must be diluted and infused by a healthcare professional for intravenous administration.
Storage Information
To ensure Stelara’s safety and effectiveness, store it in the fridge between 36°F to 46°F. Keep the vials upright in the original carton until use, and don’t shake. For prefilled syringes, you can store at room temp (up to 30°C) for 30 days.
If unused after 30 days at room temperature, discard. Do not use Stelara past the expiration date.
Side Effects
While Stelara is effective in treating various conditions, it may also lead to certain side effects.
Here are some of the common and severe side effects of Stelara:
Common Side Effects
- Nasal congestion, sore throat, and runny nose
- Upper respiratory infection
- Fever
- Headache
- Tiredness
- Itching
- Nausea and vomiting
- Redness at the injection site
- Vaginal yeast infections
- Urinary tract infections
- Sinus infection
- Bronchitis
- Diarrhea
- Stomach pain
- Joint pain
Severe but Rare Side Effects
- Feeling faint
- Swelling of your face, eyelids, tongue, or throat
- Chest tightness
- Skin rash
- Shortness of breath
- Persistent cough that doesn’t resolve
Warnings & Precautions
- Infections: Stelara may increase the risk of infections, including serious bacterial, mycobacterial, fungal, and viral infections. These can lead to conditions such as diverticulitis (inflammation of small pouches in the digestive tract), pneumonia, and gastroenteritis (inflammation of the stomach and intestines). Avoid starting treatment with Stelara in patients with any clinically important active infection until it resolves or is adequately treated.
- Risk of exposure to specific infections: Individuals genetically deficient in IL-12/IL-23 may be particularly vulnerable to disseminated infections. It’s unclear if patients receiving Stelara are susceptible to these infections, so appropriate diagnostic testing may be necessary to determine the risk.
- Assessment before tuberculosis treatment: Patients should be evaluated for tuberculosis infection before starting treatment with Stelara. Avoid giving Stelara to patients with active tuberculosis, as the medication may affect the body’s ability to fight the infection. Consider anti-tuberculosis therapy before initiating treatment in patients with a history of latent or active tuberculosis.
- Malignancies: Stelara is an immunosuppressant and may increase the risk of malignancy, which refers to the development of cancerous tumors. Malignancies were reported in clinical trials, and there have been reports of non-melanoma skin cancer in patients receiving Stelara.
- Hypersensitivity reactions: Hypersensitivity reactions, including anaphylaxis (a severe allergic reaction) and angioedema (swelling of the deeper layers of the skin), have been reported with Stelara. If a significant hypersensitivity reaction occurs, appropriate therapy should be initiated, and Stelara should be discontinued.
- Posterior Reversible Encephalopathy Syndrome (PRES): Cases of PRES have been reported in patients receiving Stelara, presenting with symptoms like headaches, seizures, and visual disturbances.
- Immunizations: Patients should receive all age-appropriate immunizations before starting Stelara, but they should avoid live vaccines while on treatment. BCG vaccines, which are used to prevent tuberculosis, should also be avoided one year before starting Stelara or one year after stopping it, as they may pose a risk of infection.
- Noninfectious pneumonia: Cases of noninfectious pneumonia have been reported with Stelara use. Symptoms may include cough and dyspnea (difficulty breathing). If diagnosed, discontinue Stelara and provide appropriate treatment, such as corticosteroids, if necessary, to reduce inflammation in the lungs.
Drug Interactions
Knowing how different medications can interact is necessary for safe treatment.
- Concurrent Therapies: In studies for conditions like Crohn’s disease and ulcerative colitis, Stelara was used alongside drugs such as azathioprine, methotrexate, and corticosteroids. Despite this combination, Stelara still showed safety and effectiveness.
- CYP450 Substrates: Stelara may affect the levels of certain enzymes in the body that help break down drugs like warfarin or cyclosporine. This means doctors might need to adjust the dosage of these medications when taken with Stelara to ensure they work correctly.
- Allergen Immunotherapy: People undergoing or who have undergone allergy shots should be cautious when taking Stelara, as it might reduce the effectiveness of allergen immunotherapy. This could increase the risk of allergic reactions, especially for severe allergies.
What to Ask Your Doctor Before Taking Stelara
Here are important questions to discuss with your doctor before starting Stelara:
- Medical Conditions: Inform your doctor about any existing medical conditions, especially those related to serious infections, cancers, or conditions like PRES (Posterior Reversible Encephalopathy Syndrome).
- Allergic Reactions: Have you ever experienced an allergic reaction to Stelara or any of its components? This includes allergies to latex, as the needle cover of the prefilled syringe contains latex.
- Immunizations: Discuss any recent or upcoming immunizations, particularly live vaccines. Stelara users should avoid live vaccines due to the risk of complications. Ensure your doctor is aware if anyone in your household requires a live vaccine.
- Psoriasis and Lesions: Notify your doctor of any new or changing lesions within psoriasis areas or on normal skin.
- Allergy Treatments: If you’re receiving or have received allergy shots, especially for severe allergic reactions, inform your doctor.
- Phototherapy: Have you undergone or are currently receiving phototherapy for your psoriasis?
- Pregnancy and Breastfeeding: Are you pregnant or planning to become pregnant? Discuss the potential risks and benefits of Stelara during pregnancy and while breastfeeding.
Cost & Ordering Information
Buy Stelara Through Buy Canadian Insulin
Buy Canadian Insulin helps patients access Stelara through participating pharmacy partners.
Pricing may vary depending on product strength, quantity selected, supplier availability, and participating pharmacy partner pricing policies.
Some patients may find pricing through participating pharmacy partners that differs from certain U.S. retail pharmacy prices.
Available services may include:
- Pricing options based on quantity selected
- Prescription processing through participating pharmacy partners
- Multiple quantity options based on prescription authorization and availability
- Shipping options to eligible U.S. delivery locations
- Customer support by phone, email, and live chat
Stelara requires a valid prescription from a licensed healthcare provider.
Prescription orders are reviewed by licensed pharmacists and healthcare professionals before dispensing, where applicable.
Stelara Discounts and Coupons
Eligible first-time customers may use coupon code FIRST10 during checkout for qualifying orders, subject to current promotional terms and conditions.
Stelara Pricing
Pricing may vary depending on strength, quantity selected, supplier availability, and participating pharmacy partner pricing policies.
Current pricing is displayed during checkout and may change without notice.
Customer Support
Phone: 1-888-525-1815
Fax: 1-888-234-1275
Email: info@buycanadianinsulin.com
Stelara Pricing
| Strength | Quantity | PG Price |
| 45mg/0.5mL | 1 syringe | $5,899 |
| 2 syringes | $11,760 | |
| 3 syringes | $17,580 | |
| 90mg/mL | 1 syringe | $6,499 |
| 2 syringes | $12,960 | |
| 3 syringes | $19,380 |
Customer Support Hours
Monday-Friday: 7am – 10pm CST
Saturday & Sunday: 9am – 5pm CST
Business Address
Buy Canadian Insulin
1026 Manitoba Avenue, Suite 1001
Selkirk, MB R1A 4M2
Canada
About Buy Canadian Insulin
Buy Canadian Insulin works with participating pharmacy partners to help patients access prescription medications.
Product availability, pricing, fulfillment location, and shipping timelines may vary depending on supplier inventory, prescription review requirements, destination location, and participating pharmacy partner availability.
Prescription orders may be fulfilled through participating licensed pharmacy partners located in Canada or other international fulfillment locations depending on product availability.
Frequently Asked Questions
Buying Stelara from Canada
FDA-Prescription, Off-Label Information, and Limitations
Dosage & Administration
Adverse Reactions
Food & Drug Interactions
Storage & Travel
Drug ComparisonDrug Comparison
Disclaimer
Buy Canadian Insulin provides educational information about medications and health conditions for informational purposes only. This content is not intended to replace professional medical advice, diagnosis, or treatment. Prescription medications require valid prescription review and processing through participating pharmacy partners. Product availability, pricing, and shipping timelines may vary. Consult your healthcare provider or pharmacist before starting, stopping, or changing any medication.
Have a prescription?
Order Stelara online today and enjoy a host of benefits, including:






